...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: How & who comes up with valuations?

I was referring to Alpine post Nex put up not long ago - I could go look for more but whatever..

i would also argue with you that zenith has had proof of success

Share
New Message
Please login to post a reply